docetaxel anhydrous has been researched along with Vulvar Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Arakawa, Y; Arita, T; Asai, J; Inoue, M; Kaneko, Y; Kanemaru, M; Katoh, N; Kondo, J; Matsui, M; Tsutsumi, M | 1 |
| Alexis, M; Awonuga, AO; Belotte, J; Bolinjkar, R; Deppe, G; Tabassum, F | 1 |
| Kris, MG; Miller, VA; Scher, HI; Sirotnak, FM; Zakowski, MF | 1 |
3 other study(ies) available for docetaxel anhydrous and Vulvar Neoplasms
| Article | Year |
|---|---|
Novel ex vivo disease model for extramammary Paget's disease using the cancer tissue-originated spheroid method.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Culture Media; Docetaxel; Dose-Response Relationship, Drug; Feasibility Studies; Female; Humans; Intercellular Signaling Peptides and Proteins; Male; Paget Disease, Extramammary; Penile Neoplasms; Primary Cell Culture; Skin Neoplasms; Spheroids, Cellular; Tumor Cells, Cultured; Vulvar Neoplasms; Xenograft Model Antitumor Assays | 2020 |
Platinum-based combination chemotherapy for the treatment of advanced-stage squamous cell carcinoma of the vulva.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Female; HIV; HIV Infections; Humans; Middle Aged; Paclitaxel; Remission Induction; Taxoids; Vulvar Neoplasms | 2012 |
Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase.
Topics: Aminopterin; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carboplatin; Cell Division; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; ErbB Receptors; Female; Gefitinib; Humans; Immunohistochemistry; Lung Neoplasms; Male; Maximum Tolerated Dose; Mice; Mice, Nude; Neoplasm Transplantation; Paclitaxel; Prostatic Neoplasms; Quinazolines; Reverse Transcriptase Polymerase Chain Reaction; Taxoids; Time Factors; Tumor Cells, Cultured; Vinblastine; Vinorelbine; Vulvar Neoplasms | 2000 |